title: Ectopic noggin blocks sensory and nonsensory organ morphogenesis in the chicken inner ear.
abstract: Bone morphogenetic protein 4 (Bmp4) is expressed during multiple stages of development of the chicken inner ear. At the otocyst stage, Bmp4 is expressed in each presumptive sensory organ, as well as in the mesenchymal cells surrounding the region of the otocyst that is destined to form the semicircular canals. After the formation of the gross anatomy of the inner ear, Bmp4 expression persists in some sensory organs and restricted domains of the semicircular canals. To address the role of this gene in inner ear development, we blocked BMP4 function(s) by delivering one of its antagonists, Noggin, to the developing inner ear in ovo. Exogenous Noggin was delivered to the developing otocyst by using a replication-competent avian retrovirus encoding the Noggin cDNA (RCAS-N) or implanting beads coated with Noggin protein. Noggin treatment resulted in a variety of phenotypes involving both sensory and nonsensory components of the inner ear. Among the nonsensory structures, the semicircular canals were the most sensitive and the endolymphatic duct and sac most resistant to exogenous Noggin. Noggin affected the proliferation of the primordial canal outpouch, as well as the continual outgrowth of the canal after its formation. In addition, Noggin affected the structural patterning of the cristae, possibly via a decrease of Msx1 and p75NGFR expression. These results suggest that BMP4 and possibly other BMPs are required for multiple phases of inner ear development.
authors.affiliation: National Institute on Deafness and Other Communication Disorders, Rockville, Maryland, 20850, USA.
authors.forename: W
authors.initials: W
authors.lastname: Chang
authors.forename: F D
authors.initials: FD
authors.lastname: Nunes
authors.forename: J M
authors.initials: JM
authors.lastname: De Jesus-Escobar
authors.forename: R
authors.initials: R
authors.lastname: Harland
authors.forename: D K
authors.initials: DK
authors.lastname: Wu
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001358:Avian Sarcoma Viruses / Q000235:genetics; D055415:Bone Morphogenetic Protein 4; D019485:Bone Morphogenetic Proteins / Q000235:genetics / Q000378:metabolism*; D001973:Bromodeoxyuridine; D002352:Carrier Proteins; D002642:Chick Embryo; D029721:Drosophila Proteins; D007758:Ear, Inner / Q000196:embryology*; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D018398:Homeodomain Proteins / Q000378:metabolism; D007150:Immunohistochemistry; D020287:In Situ Nick-End Labeling; D019476:Insect Proteins / Q000378:metabolism; D051957:MSX1 Transcription Factor; D009024:Morphogenesis / Q000187:drug effects; D017351:N-Acetylglucosaminyltransferases; D010641:Phenotype; D011506:Proteins / Q000235:genetics* / Q000494:pharmacology; D017475:Receptors, Nerve Growth Factor / Q000378:metabolism; D012665:Semicircular Canals / Q000196:embryology; D014157:Transcription Factors; D014162:Transfection; D000099176:Noggin Protein
chemical_list: D055415:Bone Morphogenetic Protein 4; D019485:Bone Morphogenetic Proteins; D001973:Bromodeoxyuridine; D002352:Carrier Proteins; D029721:Drosophila Proteins; D018398:Homeodomain Proteins; D019476:Insect Proteins; D051957:MSX1 Transcription Factor; D017351:N-Acetylglucosaminyltransferases; D011506:Proteins; D017475:Receptors, Nerve Growth Factor; D014157:Transcription Factors; D000099176:Noggin Protein; C090576:fng protein, Drosophila